Machine learning’s next frontier: epigenetic drug discovery

Sanford Burnham Prebys scientists create a machine-learning algorithm that automates high-throughput screens of epigenetic medicines.

Sanford Burnham Prebys welcomes U.S. Congressman Mike Levin

Levin tours Institute to learn more about innovative biomedical research.

New insights into how to protect premature babies from common brain disorder

Sanford Burnham Prebys scientists identify a new cause of “water on the brain” involving receptors that disrupt fluid flow.

Sanford Burnham Prebys scientist joins historic effort to help children with rare disease

The consortium is funded by a $5 million, five-year NIH grant and will address decades of unresolved questions.